Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027)
Pontiano Kaleebu(Uganda Virus Research Institute), Huyen Cao(California Health and Human Services Agency), Kenneth Kintu(MUJHU Research Collaboration), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Philippa Musoke(Centers for Disease Control and Prevention), Paul Richardson(University of Liverpool), Harr Freeya Njai(MRC Unit the Gambia), Isaac Ssewanyana(Infectious Diseases Research Collaboration), Norman G. Jones(California Health and Human Services Agency), P. Andrew(Family Health International 360), Mary Glenn Fowler(Johns Hopkins University), San-San Ou(Fred Hutch Cancer Center), Laura Guay(Johns Hopkins University), J. Brooks Jackson(VA Tennessee Valley Healthcare System), Lei Wang(Zhejiang University), Lynn Baglyos(New York Blood Center)
JAIDS Journal of Acquired Immune Deficiency Syndromes
October 3, 2013
Cited by 17
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553
Enabling the genomic revolution in Africa
|Science|2014|521